DEL FABRO, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 797
AS - Asia 544
EU - Europa 251
SA - Sud America 135
Continente sconosciuto - Info sul continente non disponibili 47
AF - Africa 13
Totale 1.787
Nazione #
US - Stati Uniti d'America 763
SG - Singapore 185
IT - Italia 116
BR - Brasile 112
HK - Hong Kong 99
BD - Bangladesh 91
CN - Cina 63
VN - Vietnam 46
FR - Francia 34
DE - Germania 25
CA - Canada 20
IE - Irlanda 17
GB - Regno Unito 16
IN - India 13
AR - Argentina 9
MX - Messico 8
NL - Olanda 8
PL - Polonia 8
TR - Turchia 8
AT - Austria 7
CO - Colombia 5
IQ - Iraq 5
CL - Cile 4
IL - Israele 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
EG - Egitto 3
ES - Italia 3
FI - Finlandia 3
ID - Indonesia 3
PK - Pakistan 3
RU - Federazione Russa 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
JP - Giappone 2
LT - Lituania 2
NP - Nepal 2
SE - Svezia 2
UZ - Uzbekistan 2
AL - Albania 1
EC - Ecuador 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
MY - Malesia 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RW - Ruanda 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 1.740
Città #
Dallas 228
Hong Kong 99
Singapore 87
San Jose 68
Ashburn 65
The Dalles 35
Chicago 32
Council Bluffs 31
Beijing 27
Phoenix 24
Santa Clara 24
Ho Chi Minh City 22
New York 22
Florence 21
Dublin 17
Rome 15
Buffalo 13
Los Angeles 9
Milan 9
São Paulo 9
Assago 8
Frankfurt am Main 8
San Francisco 7
Düsseldorf 6
Hanoi 6
Naples 6
Charlotte 5
Istanbul 5
Baghdad 4
Bexley 4
Brasília 4
Brooklyn 4
Hillsboro 4
Manchester 4
Mexico City 4
Orem 4
Toronto 4
Warsaw 4
Bogotá 3
Bologna 3
Catania 3
Da Nang 3
Jeddah 3
London 3
Mumbai 3
North Kansas City 3
Reston 3
Turin 3
Abbotsford 2
Addis Ababa 2
Atlanta 2
Baku 2
Bari 2
Belo Horizonte 2
Bemidji 2
Boston 2
Campinas 2
Cape Town 2
Changsha 2
Diadema 2
Fortaleza 2
Haiphong 2
Helsinki 2
Independencia 2
Juneau 2
Lauterbourg 2
Lençóis Paulista 2
Miami 2
Montreal 2
Newark 2
Nuremberg 2
Pittsburgh 2
Pune 2
Rio de Janeiro 2
São Bernardo do Campo 2
Tashkent 2
Tel Aviv 2
Vancouver 2
Wroclaw 2
Abbeville 1
Abu Dhabi 1
Adana 1
Agudos 1
Ahmedabad 1
Albox 1
Alegre 1
Alexandria 1
Allentown 1
Almere Stad 1
Alto Araguaia 1
Amsterdam 1
Ananindeua 1
Ancona 1
Ankara 1
Anápolis 1
Aquiraz 1
Aracaju 1
Araçatuba 1
As Sālimīyah 1
Bacabal 1
Totale 1.061
Nome #
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 90
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 74
Serum free light chains and multiple myeloma: Is it time to extend their application? 74
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over 71
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape 70
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 69
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients—A Survey from Two Italian Centers 68
Feasibility, tolerability and efficacy of carfilzomib in combination with lenalidomide and dexamethasone in relapsed refractory myeloma patients: A retrospective real-life survey of the sicilian myeloma network 67
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia 66
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 64
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects 64
Multiple Myeloma in 2023 Ways: From Trials to Real Life 62
Chemotherapy extravasation: diagnosis, prevention and management 59
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study 58
Emergencies in Hematology: Why, When and How I Treat? 58
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia 56
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 53
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? 51
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 51
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 51
Role of serum free light chain assay in relapsed/refractory multiple myeloma. A real‐life unicentric retrospective study 50
Clinical benefit of long-term disease control with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients 49
Lenalidomide and pomalidomide improve function and induce fcγri/cd64 in multiple myeloma neutrophils 48
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection 47
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 45
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review 41
Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network 35
Pericytes and mesenchymal stromal cells converge toward pro-tumor phenotypes in the tumor microenvironment 35
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 35
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 26
Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life Study 25
Diffuse large B-cell lymphoma in the new era: prognostic tools for mapping risk 23
Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experience 22
Heme oxygenase-1/CO signaling suppresses NLRP3 inflammasome-mediated stromal fibrosis in primary myelofibrosis 15
Glutamate accumulation in myelofibrosis microenvironment rewires mesenchymal stromal cells metabolic and epigenetic profiles 9
Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience 6
Totale 1.787
Categoria #
all - tutte 8.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025445 0 0 0 7 10 95 31 80 41 79 66 36
2025/20261.142 71 167 161 105 54 61 84 92 87 62 131 67
2026/2027200 18 53 78 51 0 0 0 0 0 0 0 0
Totale 1.787